According to NeoGenomics 's latest financial reports the company's total debt is $0.61 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $0.61 B | 0.12% |
2022-12-31 | $0.61 B | -0.3% |
2021-12-31 | $0.61 B | 179.57% |
2020-12-31 | $0.21 B | 64.96% |
2019-12-31 | $0.13 B | 18.32% |
2018-12-31 | $0.11 B | 6.52% |
2017-12-31 | $0.10 B | -0.7% |
2016-12-31 | $0.10 B | 48.74% |
2015-12-31 | $71.37 M | 741.63% |
2014-12-31 | $8.48 M | -18.15% |
2013-12-31 | $10.36 M | -24.73% |
2012-12-31 | $13.76 M | 59.84% |
2011-12-31 | $8.61 M | 26.94% |
2010-12-31 | $6.78 M | 90.59% |
2009-12-31 | $3.56 M | 11.7% |
2008-12-31 | $3.18 M | 195.08% |
2007-12-31 | $1.08 M | 98.77% |
2006-12-31 | $0.54 M | -61.44% |
2005-12-31 | $1.4 M | |
2003-12-31 | $0.59 M | 4264.55% |
2002-12-31 | $0.01 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Quest Diagnostics
DGX | $5.49 B | 798.84% | ๐บ๐ธ USA |
LabCorp LH | $5.95 B | 873.42% | ๐บ๐ธ USA |
RadNet RDNT | $1.49 B | 143.77% | ๐บ๐ธ USA |
Psychemedics PMD | $2.64 M | -99.57% | ๐บ๐ธ USA |
Enzo Biochem ENZ | $7.18 M | -98.83% | ๐บ๐ธ USA |